Brief: Jasper Therapeutics Appoints Daniel Adelman, M.D., As Acting Chief Medical Officer
23/03/2023 13:13
March 23 (Reuters) - Jasper Therapeutics Inc JSPR.O :
* JASPER THERAPEUTICS APPOINTS DANIEL ADELMAN, M.D., AS
ACTING
CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nGNX85zSB7
Further company coverage: JSPR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma